Skip to main content

DIADEMA PARTNERS LP

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,581,965
-$4,391,587 QoQ
Shares Held
181,752
-47.5% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
4.28%
of 13F equity value
Holder Rank
#102
of 316 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Dec 31, 2025
CallValue
$2,613,880
CallShares
64,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. TERN ranks #4 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 TERN
Terns Pharmaceuticals, Inc.
This page
181,752 $9,581,965

All Filings in TERN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,581,965 181,752
2025-12-31 $2,613,880 64,700
2025-12-31 $13,973,552 345,880
2025-09-30 $2,426,924 323,159
2025-09-30 $1,691,252 225,200
2025-06-30 $600,157 160,900
2025-06-30 $969,247 259,852
2025-03-31 $154,830 56,098
2024-12-31 $279,049 50,370